The effect of sitagliptin on obese patients with insulin treatment-induced diabetes mellitus.
CONCLUSIONS: Sitagliptin can reduce BMI and the occurrence of hypoglycemia in obese patients with insulin treatment-induced diabetes mellitus, and the effect may be related to decreased HOMA-IR, decreased leptin and visfatin levels, and increased adiponectin levels.
PMID: 28829491 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cholesterol | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Fortamet | Insulin | Janumet | Januvia | Metformin | Obesity | Statistics | Study